Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain, from development and approval, to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.
Qualitas Funds' News
Return to Qualitas Funds news
Qualitas Funds Direct II– Acquisition of Develco Pharma
We are delighted to announce that Develco Pharma has been added to the Qualitas Funds Direct II portfolio. This transaction was led by one of our managers located in Germany.
Other news from Portfolio transactions
Qualitas Funds Direct II– Acquisition of Compass
We are pleased to announce that Compass has been added to the Qualitas Funds Direct II portfolio. This co-investment has been made with one of our GPs in the UK.
Read more
Qualitas Funds V – Acquisition of kShuttle
We are delighted to announce that kShuttle has been added to the Qualitas Funds V portfolio. This transaction was led by one of our managers located in France.
Read more